Cargando…

Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator

BACKGROUND: The survival outcome following a sudden cardiac arrest (SCA) in hemodialysis (HD) patients is poor regardless of whether an event takes place in or out of a dialysis center. The characteristics of SCA and post‐SCA survival with HD patients using a wearable cardioverter defibrillator (WCD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Chingping, Herzog, Charles A., Zareba, Wojciech, Szymkiewicz, Steven J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034590/ https://www.ncbi.nlm.nih.gov/pubmed/24252154 http://dx.doi.org/10.1111/anec.12119

Ejemplares similares

Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
por: Wäßnig, Nadine K., et al.
Publicado: (2016)

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator
por: Skowasch, Dirk, et al.
Publicado: (2018)

PO-632-07 EFFECTIVENESS OF THE WEARABLE CARDIOVERTER DEFIBRILLATOR IN PATIENTS WITH COVID-19
por: Bianco, Nicole, et al.
Publicado: (2022)

Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
por: Kutyifa, Valentina, et al.
Publicado: (2018)

Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2011)

Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis
por: Nguyen, Elaine, et al.
Publicado: (2018)

Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study
por: Ettinger, Sabine, et al.
Publicado: (2017)

Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis
por: Andrié, René, et al.
Publicado: (2017)

Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
por: Israel, Carsten, et al.
Publicado: (2022)

Critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
por: Sperzel, Johannes, et al.
Publicado: (2018)

Refractory Vasospastic Angina and Sudden Cardiac Arrest: Is Implantable Cardioverter Defibrillator Indicated and Is It Always Protective?
por: Riaz, Sana, et al.
Publicado: (2020)

Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study
por: Garcia, Rodrigue, et al.
Publicado: (2020)

Mortality and Costs Associated with Wearable Cardioverter-defibrillators after Acute Myocardial Infarction: A Retrospective Cohort Analysis of Medicare Claims Data
por: Clark, Mary Ann, et al.
Publicado: (2019)

Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death
por: Kuehn, Christian, et al.
Publicado: (2022)

Wearable cardioverter defibrillator after cardiac surgery: Analysis of real‐life data from patients at transient risk of sudden cardiac death
por: Elbayomi, Mohamed, et al.
Publicado: (2023)

Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
por: Sperzel, Johannes, et al.
Publicado: (2018)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Multiparameter Monitoring with a Wearable Cardioverter Defibrillator
por: Rohrer, Ursula, et al.
Publicado: (2021)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

Experience with a Wearable Cardioverter-defibrillator in 436 Patients
por: Nägele, Herbert, et al.
Publicado: (2022)

Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
por: Ettinger, Sabine, et al.
Publicado: (2019)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
por: Klopotowski, Mariusz, et al.
Publicado: (2022)

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death
por: Casolo, Giancarlo, et al.
Publicado: (2023)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
por: Vinas, Ariel, et al.
Publicado: (2021)

Phantom Shocks Associated With a Wearable Cardioverter Defibrillator
por: Delle Donna, Paul, et al.
Publicado: (2021)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
por: Blaschke, Florian, et al.
Publicado: (2021)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
por: Bhatt, Advay G., et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is needed for most high-risk patients
por: Lee, Byron K.
Publicado: (2020)

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
por: Ahmed, Imdad, et al.
Publicado: (2010)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
por: Lebedeva, Viktoria K., et al.
Publicado: (2018)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Prevention of Early Sudden Cardiac Death after Myocardial Infarction Using the Wearable Cardioverter Defibrillator—Results from a Real-World Cohort
por: Rohrer, Ursula, et al.
Publicado: (2023)

Epidural Blood Patch Placement with Patient Wearing Wearable Cardioverter Defibrillator: To be or Not to be
por: Gupta, Deepak
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1nvdtts7501552lv7kh3v7tchs